Loading...
Loading...
Application UK00902126464 · Dead

| Application Number | UK00902126464 |
| Status | Dead |
| Owner | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| Filed | 2001-03-13 |
| Registered | 2002-08-14 |
| Renewal Due | 2021-03-13 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
UK00902126464 has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical products.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
This device mark (application number UK00902126464) is a dead trademark on the UK IPO register, filed by CHUGAI SEIYAKU KABUSHIKI KAISHA on 13 March 2001, with registration granted on 14 August 2002. It is due to expire on 13 March 2021.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by ELZABURU, S.L.P..
No — the UK IPO records the status of UK trademark UK00902126464 as dead.
UK trademark UK00902126464 is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical products.
UK trademark UK00902126464 was filed at the UK IPO on 13 March 2001 and registered on 14 August 2002.
UK trademark UK00902126464 is currently recorded as valid until 13 March 2021, at which point it will need to be renewed with the UK IPO to remain in force.
ELZABURU, S.L.P. is listed as the attorney / representative of record for UK trademark UK00902126464 on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.